Document is current
Any future updates will be listed below
-
Authors
Alsaleh, Saad https://orcid.org/0000-0002-1236-2098
Alhussien, Ahmed https://orcid.org/0000-0003-4754-0293
Alyamani, Abduljabbar https://orcid.org/0000-0002-2495-7523
Alhussain, Fahad https://orcid.org/0000-0002-9655-9698
Alhijji, Ali https://orcid.org/0000-0003-2074-8916
Binkhamis, Khalifa https://orcid.org/0000-0002-5425-9531
Khan, Anas https://orcid.org/0000-0001-5075-7392
Javer, Amin https://orcid.org/0000-0003-3116-6559
Alshahrani, Fatimah S. https://orcid.org/0000-0002-4646-7488
- License Information
-
More Information
Article History
Received: 6 October 2023
Accepted: 14 February 2024
First Online: 1 March 2024
Declarations
:
: The study was approved by the King Saud University Institutional Review Board and the Saudi Food and Drug Authority Clinical Trial Unit. All patients who met the inclusion criteria signed a written informed consent form that mentioned possible risks and benefits associated with the intervention.
: Not applicable.
: The authors declare no competing interests.
